Recombinant CD22 (Inotuzumab Biosimilar) antibody
The Humanized Chimeric anti-CD22 (Inotuzumab Biosimilar) antibody (ABIN7597751) specifically detects CD22 (Inotuzumab Biosimilar).
The antibody is reactive with Human samples.
Catalog No. ABIN7597751
$401.14
Plus shipping costs $50.00, if applicable $20.00 dry ice
Shipping to:
United States
Delivery in 12 to 15 Business Days
Quick Overview for Recombinant CD22 (Inotuzumab Biosimilar) antibody (ABIN7597751)
Target
CD22 (Inotuzumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Humanized
Clonality
Chimeric
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Research Grade Inotuzumab Biosimilar Antibody
-
Specificity
- Sialic acid-binding Ig-like lectin 2, Siglec-2, CD22, T-cell surface antigen Leu-14, BL-CAM, SIGLEC2, B-lymphocyte cell adhesion molecule, B-cell receptor CD22
-
Purification
- Protein A or G purified from cell culture supernatant.
-
Purity
- >95 % by SDS-PAGE.
-
Isotype
- IgG4 kappa
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4.
-
Storage
- 4 °C,-20 °C,-80 °C
-
Storage Comment
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.
-
Expiry Date
- 12 months
-
-
- CD22 (Inotuzumab Biosimilar)
-
Alternative Name
- Inotuzumab Biosimilar
-
Target Type
- Biosimilar
-
Background
- Sialic acid-binding Ig-like lectin 2, Siglec-2, CD22, T-cell surface antigen Leu-14, BL-CAM, SIGLEC2, B-lymphocyte cell adhesion molecule, B-cell receptor CD22
-
UniProt
- P20273
-
CAS-No
- 1660159-36-3
Target
-
You are here:
